Krux Pharma Private Limited, a active private limited company, was established on 17 October 2016 in Valsad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24302GJ2016PTC094103. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Employing 42 professional, Its leadership includes Imran Shabbir Hussain Siroha (Director), Salim Diwan Salaudeen Chopdar (Director). Past directors included Digambar Jaikishan Zawar, Mahboob Diwan Chopdar. It holds ₹11.77 Cr open charges and ₹31.49 Cr settled loans. Its latest AGM occurred on 16 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 10 & 11, Survey No. 256/P1 Nr. Balda Industrial Parkvillage Balda,, Ta. Pardi, Valsad, Gujarat, 396125.
U24302GJ2016PTC094103
094103
17 October 2016
₹3.00 Cr
₹3.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Krux Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Imran Shabbir Hussain Siroha | Director | 17 Oct 2016 | Current |
| Salim Diwan Salaudeen Chopdar | Director | 18 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2021 | Past |
| Pramod Abcsdd | Additional Director | 28 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Krux Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 45.11% increase. The company also saw a substantial fall in profitability, with a 12.94% decrease in profit. The company's net worth moved up by a moderate rise of 2.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Krux Pharma had a promoter holding of 33.33% and a public holding of 66.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹117,707,309.00
₹314,945,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2023 | Yes Bank Limited | ₹11.77 Cr | Open |
| 03 Jul 2021 | Hdfc Bank Limited | ₹11.59 Cr | Satisfied |
| 09 Oct 2018 | Indian Bank | ₹9.95 Cr | Satisfied |
| 05 Oct 2018 | Indian Bank | ₹9.95 Cr | Satisfied |
Explore comprehensive loan charge details -
Krux Pharma has a workforce of 42 employees as of Feb 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Krux Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krux Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Krux Pharma Private Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records. was documented.
Progress on Krux Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on A charge with Yes Bank Limited of Rs. 11.77 Cr registered on 25 Aug 2023 with Charge ID 100790704 was modified on 20 Mar 2024. was documented.
The activity Salim Diwan Salaudeen Chopdar was appointed as a Director was appointed as a Director on 18 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
A charge registered on 03 Jul 2021 via Charge ID 100458144 with Hdfc Bank Limited was fully satisfied on 03 Nov 2023. was recorded as a recent event.
A charge with Yes Bank Limited amounted to Rs. 11.77 Cr with Charge ID 100790704 was registered on 25 Aug 2023. was recorded as a recent event.
The CIN of Krux Pharma Private Limited is U24302GJ2016PTC094103.
Krux Pharma Private Limited is headquartered at Plot No. 10 & 11, Survey No. 256/P1 Nr. Balda Industrial Parkvillage Balda,, Ta. Pardi, Valsad, Gujarat, 396125.
Krux Pharma Private Limited was incorporated on 17 October 2016.
The current directors of Krux Pharma Private Limited are
The primary industry of Krux Pharma Private Limited is Manufacturing.
Krux Pharma Private Limited is unlisted.
The authorized capital of Krux Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Krux Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX